
Time | Title | speaker, Institution |
---|---|---|
8:30 – 8:35 a.m. | Welcome Remarks | Jonathan D. Licht, M.D., University of Florida |
IMMUNOTHERAPY PRINCIPLES | ||
8:35 – 9:05 a.m. | Role of Microbiota in Immunotherapy Response and Toxicity | Christian Jobin, Ph.D., University of Florida |
9:05 – 9:35 a.m. | New Advances In Vaccines & Adoptive Cellular Therapies | Duane Mitchell, M.D., Ph.D., University of Florida |
9:35 – 9:50 a.m. | Q&A | |
CLINICAL UPDATES & RECENT IMMUNO-ONCOLOGY APPROVALS | ||
9:50 – 10:05 a.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Neuro & Pediatrics | Elias Sayour, M.D., Ph.D., University of Florida |
10:05 – 10:20 a.m. | Recent Approvals and Clinical Updates for Car-T Cell Therapy | Jack W. Hsu, M.D., University of Florida |
10:20 – 10:50 a.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Breast Cancer | Leisha A. Emens, M.D., Ph.D., University of Pittsburgh Cancer Center |
10:50 – 11:05 a.m. | Q&A | |
11:05 – 11:20 a.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Gynecologic Cancers | Martina Murphy, M.D., University of Florida |
11:20 – 11:35 a.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Genitourinary Cancers | Jonathan A. Chatzkel, M.D., University of Florida |
11:35 – 11:55 a.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Gastrointestinal Cancers | Sherise Rogers, M.D., M.P.H., University of Florida |
11:55 – 12:25 p.m. | Recent Approvals and Clinical Updates for Immuno-Oncology in Lung and Head & Neck Cancers | Devika Das, M.D., The University of Alabama at Birmingham |
12:25 – 12:40 p.m. | Q&A | |
12:40 – 1 p.m. | Lunch | |
TOXICITY MANAGEMENT AND SPECIAL POPULATIONS | ||
1 – 1:30 p.m. | Management of Acute and Chronic Immune Reactions | Brian H. Ramnaraign, M.D., University of Florida |
1:30 – 2 p.m. | Immuno-Oncology Management in Special Populations: Autoimmune Diseases; Poor Performance Status; Elderly and Diabetic Patients; Covid19 Positive Patients | Panel Discussion moderated by: David DeRemer, Pharm.D., BCOP with: Brian H. Ramnaraign, M.D., Zeina A. Al-Mansour, M.D., Dennie Jones, Jr, M.D., University of Florida |
FUTURE DIRECTIONS | ||
2 – 2:30 p.m. | Rational Approaches and Future Directions in Immuno-Oncology Therapies | Samir N. Khleif, M.D., Georgetown University Cancer Center |
2:30 – 2:45 p.m. | Q&A | |
2:45 – 2:50 p.m. | Closing Remarks | Jonathan D. Licht, M.D., University of Florida |